Delivery Order SPE2DB24D1021-SPE2DB25FFASV
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,651.43 to AmerisourceBergen Drug Corp for the supply of Quelipita 60 mg tablets (30-count packages) on September 5, 2025, with an ultimate completion date of September 8, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract is being performed at...
- The Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $64,765.81 on September 8, 2025, for the supply of Queliptta 60 mg tablets (30-count) with an ultimate completion date of October 3, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a $1,738.19 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Quelipita 60 mg tablets (30-count). This firm fixed-price, non-set-aside contract is scheduled for completion by September 17, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was competitively selected to fulfill this medical...
- The Defense Logistics Agency awarded a $4,027.02 delivery order to AmerisourceBergen Drug Corp for Quilpta 60 mg tablets (30-count package) on August 1, 2025, with an ultimate completion date of August 4, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency awarded a $26,473.25 delivery order to AmerisourceBergen Drug Corp for Qualipta 60 mg tablets (30-count units) on September 8, 2025, with an ultimate completion date of September 9, 2025. This firm fixed-price, competitively awarded contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Quilpta 60 mg tablets (30-count units) with a ceiling value of $2,073.71 and a firm fixed price structure. This is a non-set-aside, competitively awarded contract with an ultimate completion date of September 2, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a small-value transaction...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Queliptra 60 mg tablets (30-count packaging) with a ceiling value of $1,864.09. This firm fixed-price delivery order, which is not set-aside designated, was competitively awarded and reflects AmerisourceBergen's role as a critical pharmaceutical distributor supporting federal medical procurement needs. The contract is scheduled for completion by September 8,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 25, 2025, for the supply of Qualiptia 60 mg tablets in a quantity of 30 units, with a contract ceiling value of $3,736.62. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The contract is scheduled for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Quilpta 60 mg tablets (30-count) valued at $17,728.24 under a firm fixed-price contract type. The award was made on June 27, 2025, with an ultimate completion date of June 30, 2025, with performance to occur at the vendor's location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Quilpta 60 mg tablets (30-count) with a ceiling value of $4,155.56. This is a firm fixed-price delivery order with an ultimate completion date of July 30, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 billion through December 2026. The contract is non-competitive...
- SPE2DB24D1021Indefinite Delivery Contract
- SPE2DB24D1021-SPE2DB25FFASVDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $18,166.12 to AmerisourceBergen Drug Corp for the supply of Quelipat 60 mg tablets (30-count units). This non-competitive delivery order was issued on September 16, 2025, with an ultimate completion date of September 17, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract employs firm fixed pricing and represents a single delivery order under an existing indefinite delivery contract. This delivery order is a child contract executed under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply pharmaceuticals and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor, AmerisourceBergen leverages this contract vehicle to fulfill federal medical procurement requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems across multiple therapeutic domains. The company's selection reflects its demonstrated capability to meet federal procurement standards through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.2k | 9/16/25 |